BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31188774)

  • 1. In Silico and in Vitro Studies of Fluorinated Chroman-2-Carboxilic Acid Derivatives as an Anti-tubercular Agent.
    Kapadiya KM; Jadeja YS; Banik A; Khunt RC
    Folia Med (Plovdiv); 2018 Dec; 60(4):601-609. PubMed ID: 31188774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation.
    Dongamanti A; Aamate VK; Devulapally MG; Gundu S; Balabadra S; Manga V; Yogeeswari P; Sriram D; Balasubramanian S
    Mol Divers; 2017 Nov; 21(4):999-1010. PubMed ID: 28840414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis and Biological Evaluation of Novel Spiro-[Chroman-2,4'-Piperidin]-4-One Analogs as Anti-Tubercular Agents.
    Chitti S; Nandikolla A; Khetmalis YM; Van Calster K; Kumar BVS; Kumar BK; Murugesan S; Cappoen D; Sekhar KVGC
    Chem Biodivers; 2022 Aug; 19(8):e202200304. PubMed ID: 35821618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.
    Venugopala KN; Chandrashekharappa S; Deb PK; Tratrat C; Pillay M; Chopra D; Al-Shar'i NA; Hourani W; Dahabiyeh LA; Borah P; Nagdeve RD; Nayak SK; Padmashali B; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Haroun M; Shashikanth S; Mohanlall V; Mailavaram R
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1472-1487. PubMed ID: 34210233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis.
    Liu P; Yang Y; Ju Y; Tang Y; Sang Z; Chen L; Yang T; An Q; Zhang T; Luo Y
    Bioorg Chem; 2018 Oct; 80():422-432. PubMed ID: 30005200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
    Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
    Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tubercular agents from Glycyrrhiza glabra.
    Kalani K; Chaturvedi V; Alam S; Khan F; Srivastava SK
    Curr Top Med Chem; 2015; 15(11):1043-9. PubMed ID: 25786503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32.
    Kawate T; Iwase N; Shimizu M; Stanley SA; Wellington S; Kazyanskaya E; Hung DT
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6052-9. PubMed ID: 24103299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study.
    Bhatt JD; Chudasama CJ; Patel KD
    Bioorg Med Chem; 2015 Dec; 23(24):7711-6. PubMed ID: 26631439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents.
    Kumar G; Sathe A; Krishna VS; Sriram D; Jachak SM
    Eur J Med Chem; 2018 Sep; 157():1-13. PubMed ID: 30064024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and in silico study of pyridine based 1,3,4-oxadiazole embedded hydrazinecarbothioamide derivatives as potent anti-tubercular agent.
    Ambhore AN; Kamble SS; Kadam SN; Kamble RD; Hebade MJ; Hese SV; Gaikwad MV; Meshram RJ; Gacche RN; Dawane BS
    Comput Biol Chem; 2019 Jun; 80():54-65. PubMed ID: 30901601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrids of thienopyrimidinones and thiouracils as anti-tubercular agents: SAR and docking studies.
    Pisal MM; Nawale LU; Patil MD; Bhansali SG; Gajbhiye JM; Sarkar D; Chavan SP; Borate HB
    Eur J Med Chem; 2017 Feb; 127():459-469. PubMed ID: 28103537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
    Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Sriram D; Yogeeswari P; Sridevi JP; Guru Row TN; Hosamani AA; Sujan Ganapathy PS; Chandrika N; Narendra LV
    Eur J Med Chem; 2015 Jan; 89():616-27. PubMed ID: 25462270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting HIV-TB coinfection by developing novel piperidin-4-substituted imines: Design, synthesis, in vitro and in silico studies.
    Kumar A; Revathi R; Sriram D; Curreli F; Debnath AK; Pai KS; Kini SG
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800358. PubMed ID: 31066103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.
    Jadhavar PS; Dhameliya TM; Vaja MD; Kumar D; Sridevi JP; Yogeeswari P; Sriram D; Chakraborti AK
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2663-9. PubMed ID: 27095514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound Assisted Synthesis of 4-(Benzyloxy)-
    Nimbalkar UD; Seijas JA; Borkute R; Damale MG; Sangshetti JN; Sarkar D; Nikalje APG
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30081525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents.
    Atmaram Upare A; Gadekar PK; Sivaramakrishnan H; Naik N; Khedkar VM; Sarkar D; Choudhari A; Mohana Roopan S
    Bioorg Chem; 2019 May; 86():507-512. PubMed ID: 30776681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
    Venugopala KN; Chandrashekharappa S; Pillay M; Abdallah HH; Mahomoodally FM; Bhandary S; Chopra D; Attimarad M; Aldhubiab BE; Nair AB; Sreeharsha N; Morsy MA; Pottathil S; Venugopala R; Odhav B; Mlisana K
    PLoS One; 2019; 14(6):e0217270. PubMed ID: 31163040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.